StockDuty ← Dashboard Sep 02, 2026 12:24 PM ET
SignalCorporate

OWKIN SIGNS AI DRUG DISCOVERY DEAL WITH BOEHRINGER FOR CANCER, IMMUNOLOGY

Corporate AI drug discovery deal pairs Boehringer’s scale with Owkin’s platform.

What changed
Why it matters
Corporate AI drug discovery deal pairs Boehringer’s scale with Owkin’s platform.
Sources
cna
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →$FMX →